Craniocerebral injury
RecruitingStudy on Dopaminergic Pathway Disruption in Comatose Patients with Traumatic Brain Injury Using [18F]LBT-999
Study on Dopaminergic Pathway Disruption in Comatose Patients with Traumatic Brain Injury Using [18F]LBT-999
- Disease:Craniocerebral injury
- Substances:METHYL (1R,2S,3S,5S)-8-[(E)-4-(18F)FLUORANYLBUT-2-ENYL]-3-(4-METHYLPHENYL)-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE
France- Participants:18–64 years · Healthy volunteers
- Substances:METHYL (1R,2S,3S,5S)-8-[(E)-4-(18F)FLUORANYLBUT-2-ENYL]-3-(4-METHYLPHENYL)-8-AZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE
- Sponsor:Inserm
